PharmaTimes speaks to AI expert Jackie Hunter about the future of these technologies in R&D

PharmaTimes joined us at PiR’s June Breakfast Briefing in London where they joined our speaker AI expert Jackie Hunter, CEO BenevolentBio who talked about the future of these technologies in R&D

See the article in Pharma Times

Professor Jackie Hunter, CEO BenevolentBio

Team at the Royal Society of Chemistry

Leave a Reply

Your email address will not be published.